Humana Company Profile (NYSE:HUM)

About Humana (NYSE:HUM)

Humana logoHumana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care - NEC
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:HUM
  • CUSIP: 44485910
  • Web:
  • Market Cap: $34.03378 billion
  • Outstanding Shares: 144,315,000
Average Prices:
  • 50 Day Moving Avg: $235.90
  • 200 Day Moving Avg: $218.69
  • 52 Week Range: $163.50 - $243.74
  • Trailing P/E Ratio: 24.04
  • Foreward P/E Ratio: 19.53
  • P/E Growth: 1.63
Sales & Book Value:
  • Annual Revenue: $54.34 billion
  • Price / Sales: 0.63
  • Book Value: $70.91 per share
  • Price / Book: 3.33
  • Annual Dividend: $1.60
  • Dividend Yield: 0.7%
  • EBIDTA: $2.27 billion
  • Net Margins: 2.71%
  • Return on Equity: 14.38%
  • Return on Assets: 5.44%
  • Debt-to-Equity Ratio: 0.47%
  • Current Ratio: 1.65%
  • Quick Ratio: 1.65%
  • Average Volume: 1.47 million shs.
  • Beta: 0.91
  • Short Ratio: 3.51

Frequently Asked Questions for Humana (NYSE:HUM)

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Thursday, April 20th. Investors of record on Friday, June 30th will be given a dividend of $0.40 per share on Monday, July 31st. This represents a $1.60 annualized dividend and a yield of 0.68%. The ex-dividend date of this dividend is Wednesday, June 28th. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana declared that its board has authorized a share buyback program on Tuesday, April 11th 2017, which authorizes the company to buyback $2,250,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 7.3% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's management believes its stock is undervalued.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) posted its quarterly earnings data on Wednesday, May, 3rd. The company reported $2.75 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.55 by $0.20. The firm had revenue of $13.76 billion for the quarter, compared to the consensus estimate of $13.61 billion. Humana had a return on equity of 14.38% and a net margin of 2.71%. During the same period in the previous year, the firm posted $1.86 EPS. View Humana's Earnings History.

When will Humana make its next earnings announcement?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, August, 2nd 2017. View Earnings Estimates for Humana.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY17 earnings guidance on Wednesday, May, 3rd. The company provided EPS guidance of $11.10+ for the period, compared to the Thomson Reuters consensus earnings per share estimate of $11.15.

Where is Humana's stock going? Where will Humana's stock price be in 2017?

19 brokerages have issued 12-month price targets for Humana's stock. Their predictions range from $170.00 to $275.00. On average, they anticipate Humana's share price to reach $231.47 in the next year. View Analyst Ratings for Humana.

Who are some of Humana's key competitors?

Who are Humana's key executives?

Humana's management team includes the folowing people:

  • Kurt J. Hilzinger, Independent Chairman of the Board
  • Bruce D. Broussard, President, Chief Executive Officer, Director
  • Brian A. Kane, Chief Financial Officer, Senior Vice President
  • Timothy S. Huval, Chief Human Resource Officer, Senior Vice President
  • Brian P. LeClaire, Senior Vice President, Chief Information Officer
  • Sam Deshpande, Senior Vice President, Chief Risk Officer
  • Christopher M. Todoroff, Senior Vice President, General Counsel
  • Roy A. Beveridge M.D., Senior Vice President, Chief Medical Officer
  • Jody L. Bilney, Senior Vice President, Chief Consumer Officer
  • Christopher H. Hunter, Senior Vice President, Chief Strategy Officer

Who owns Humana stock?

Humana's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Bank of Montreal Can (0.26%), APG Asset Management N.V. (0.17%), National Pension Service (0.09%), Chevy Chase Trust Holdings Inc. (0.09%), Aperio Group LLC (0.07%) and Hermes Investment Management Ltd. (0.05%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge and Timothy S Huval. View Institutional Ownership Trends for Humana.

Who sold Humana stock? Who is selling Humana stock?

Humana's stock was sold by a variety of institutional investors in the last quarter, including Exxonmobil Investment Management Inc. TX, Chevy Chase Trust Holdings Inc., NN Investment Partners Holdings N.V., State Treasurer State of Michigan, First Quadrant L P CA, Hermes Investment Management Ltd., Central Bank & Trust Co. and Huntington National Bank. Company insiders that have sold Humana stock in the last year include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge and Timothy S Huval. View Insider Buying and Selling for Humana.

Who bought Humana stock? Who is buying Humana stock?

Humana's stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, APG Asset Management N.V., CHURCHILL MANAGEMENT Corp, Meeder Asset Management Inc., Aperio Group LLC, Mn Services Vermogensbeheer B.V., National Pension Service and Nisa Investment Advisors LLC. View Insider Buying and Selling for Humana.

How do I buy Humana stock?

Shares of Humana can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of Humana stock can currently be purchased for approximately $235.92.

MarketBeat Community Rating for Humana (NYSE HUM)
Community Ranking:  2.3 out of 5 ( )
Outperform Votes:  483 (Vote Outperform)
Underperform Votes:  552 (Vote Underperform)
Total Votes:  1,035
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Humana (NYSE:HUM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 7 Hold Ratings, 12 Buy Ratings
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $231.47 (1.88% downside)

Analysts' Ratings History for Humana (NYSE:HUM)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/14/2017Piper Jaffray CompaniesReiterated RatingBuy$246.00LowView Rating Details
7/14/2017Cowen and CompanyReiterated RatingBuy$230.00LowView Rating Details
7/14/2017Bank of America CorporationBoost Price TargetBuy$270.00 -> $275.00LowView Rating Details
7/13/2017Credit Suisse GroupReiterated RatingOutperform$245.00 -> $250.00LowView Rating Details
6/28/2017Citigroup Inc.Initiated CoverageBuy -> Buy$275.00MediumView Rating Details
6/23/2017Cantor FitzgeraldReiterated RatingNot Available -> NeutralLowView Rating Details
6/9/2017ArgusUpgradeHold -> Buy$260.00LowView Rating Details
6/6/2017Morgan StanleyInitiated CoverageOverweight -> Overweight$262.00LowView Rating Details
6/5/2017Royal Bank Of CanadaReiterated RatingHold$214.00LowView Rating Details
5/30/2017Leerink SwannBoost Price TargetOutperform$250.00 -> $265.00LowView Rating Details
5/10/2017Deutsche Bank AGLower Price TargetHold$234.00 -> $216.00LowView Rating Details
5/4/2017Jefferies Group LLCReiterated RatingHold$221.00 -> $230.00HighView Rating Details
4/25/2017Evercore ISIReiterated RatingOutperform$240.00LowView Rating Details
3/30/2017CIBCReiterated RatingOutperformLowView Rating Details
3/30/2017Oppenheimer Holdings, Inc.Initiated CoverageOutperform -> Outperform$236.00 -> $236.00LowView Rating Details
1/24/2017Stifel NicolausDowngradeBuy -> Hold$214.00 -> $210.00N/AView Rating Details
1/9/2017Barclays PLCReiterated RatingHold$217.00N/AView Rating Details
12/4/2016Susquehanna Bancshares IncReiterated RatingNeutral$180.00 -> $200.00N/AView Rating Details
11/10/2016J P Morgan Chase & CoUpgradeNeutral -> Overweight$163.00 -> $202.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMkt Perform$220.00 -> $170.00N/AView Rating Details
7/21/2016Wolfe ResearchUpgradeOutperform$192.00N/AView Rating Details
(Data available from 7/22/2015 forward)


Earnings History for Humana (NYSE:HUM)
Earnings by Quarter for Humana (NYSE:HUM)
Earnings History by Quarter for Humana (NYSE HUM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2017Q1 2017$2.55$2.75$13.61 billion$13.76 billionViewN/AView Earnings Details
2/8/2017Q416$2.05$2.09$13.55 billion$12.88 billionViewN/AView Earnings Details
11/4/2016Q316$3.09$3.18$13.41 billion$13.69 billionViewN/AView Earnings Details
8/3/2016Q216$2.23$2.30$13.59 billion$14.00 billionViewN/AView Earnings Details
5/4/2016Q1$1.81$1.86$13.80 billion$13.80 billionViewN/AView Earnings Details
2/10/2016Q415$1.45$1.45$13.51 billion$13.40 millionViewN/AView Earnings Details
11/6/2015Q315$2.13$2.16$13.64 billion$13.36 billionViewN/AView Earnings Details
7/29/2015Q215$1.63$1.67$13.81 billion$13.73 billionViewN/AView Earnings Details
4/29/2015Q115$2.54$2.47$13.51 billion$13.80 billionViewListenView Earnings Details
2/4/2015Q414$1.16$1.09$12.41 billion$12.23 millionViewListenView Earnings Details
11/7/2014Q314$2.01$1.85$12.34 billion$12.24 billionViewListenView Earnings Details
7/30/2014Q214$2.19$2.19$11.93 billion$12.22 billionViewListenView Earnings Details
5/7/2014Q114$1.94$2.35$11.45 billion$11.71 billionViewListenView Earnings Details
2/5/2014Q413$0.95($0.19)$10.23 billion$10.20 billionViewListenView Earnings Details
11/6/2013Q313$2.14$2.31$10.27 billion$10.00 billionViewListenView Earnings Details
7/31/2013Q2 2013$2.46$2.63$10.36 billion$10.32 billionViewListenView Earnings Details
5/1/2013Q1 2013$1.80$2.95$10.23 billion$10.49 billionViewListenView Earnings Details
2/4/2013Q4 2012$1.07$1.19$9.73 billion$9.56 billionViewListenView Earnings Details
11/5/2012Q312$2.05$2.62$9.86 billion$9.65 billionViewN/AView Earnings Details
7/30/2012$2.21$2.16ViewN/AView Earnings Details
4/30/2012$1.54$1.49ViewN/AView Earnings Details
2/6/2012$1.20$1.20ViewN/AView Earnings Details
10/31/2011$2.03$2.54ViewN/AView Earnings Details
8/1/2011$2.05$2.50ViewN/AView Earnings Details
5/2/2011$1.86$1.86ViewN/AView Earnings Details
2/7/2011$0.81$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Humana (NYSE:HUM)
2017 EPS Consensus Estimate: $10.69
2018 EPS Consensus Estimate: $13.58
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.07$2.75$2.36
Q2 20174$2.37$3.29$3.00
Q3 20174$3.15$3.44$3.26
Q4 20174$1.77$2.56$2.08
Q1 20181$2.95$2.95$2.95
Q2 20181$3.41$3.41$3.41
Q3 20181$3.61$3.61$3.61
Q4 20181$3.61$3.61$3.61
(Data provided by Zacks Investment Research)


Current Dividend Information for Humana (NYSE:HUM)
Next Dividend:7/31/2017
Annual Dividend:$1.60
Dividend Yield:0.68%
Dividend Growth:3.10% (3 Year Average)
Payout Ratio:16.24% (Trailing 12 Months of Earnings)
14.41% (Based on This Year's Estimates)
13.25% (Based on Next Year's Estimates)
Track Record:6 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Humana (NYSE:HUM)

Dividend History by Quarter for Humana (NYSE HUM)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Humana (NYSE:HUM)
Insider Ownership Percentage: 0.80%
Institutional Ownership Percentage: 99.04%
Insider Trades by Quarter for Humana (NYSE:HUM)
Institutional Ownership by Quarter for Humana (NYSE:HUM)
Insider Trades by Quarter for Humana (NYSE:HUM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/28/2017Brian P LeclaireSVPSell4,971$240.00$1,193,040.00View SEC Filing  
5/26/2017Heidi S MargulisVPSell1,500$231.96$347,940.00View SEC Filing  
5/5/2017Jody L BilneySVPSell4,600$230.16$1,058,736.00View SEC Filing  
5/4/2017Bruce D BroussardCEOSell118,231$225.82$26,698,924.42View SEC Filing  
5/4/2017Timothy S HuvalVPSell13,939$225.86$3,148,262.54View SEC Filing  
3/21/2017Jody L BilneySVPSell4,348$213.80$929,602.40View SEC Filing  
3/6/2017James E MurrayCOOSell31,151$213.62$6,654,476.62View SEC Filing  
3/3/2017Cynthia H ZipperleVPSell1,885$213.37$402,202.45View SEC Filing  
2/24/2017Brian P LeclaireSVPSell4,971$204.81$1,018,110.51View SEC Filing  
2/22/2017Brian P LeclaireSVPSell26,894$205.24$5,519,724.56View SEC Filing  
2/22/2017James E MurrayCOOSell9,523$204.69$1,949,262.87View SEC Filing  
2/22/2017Roy A BeveridgeVPSell4,832$205.73$994,087.36View SEC Filing  
2/21/2017Bruce D BroussardCEOSell104,256$205.23$21,396,458.88View SEC Filing  
2/21/2017Cynthia H ZipperleCAOSell4,213$204.67$862,274.71View SEC Filing  
2/21/2017David A. Jr/Ky JonesDirectorSell27,000$205.04$5,536,080.00View SEC Filing  
2/21/2017James E MurrayCOOSell70,332$205.20$14,432,126.40View SEC Filing  
2/21/2017Jody L BilneySVPSell6,087$204.72$1,246,130.64View SEC Filing  
2/21/2017M Todoroff ChristopherVPSell24,140$205.33$4,956,666.20View SEC Filing  
2/25/2016Brian P LeclaireSVPSell183$176.11$32,228.13View SEC Filing  
3/11/2015James E MurrayCOOSell35,220$160.90$5,666,898.00View SEC Filing  
3/2/2015Brian P LeclaireSVPSell5,500$161.79$889,845.00View SEC Filing  
2/25/2015Bruce D BroussardCEOSell41,105$165.29$6,794,245.45View SEC Filing  
2/25/2015David A Jr/Ky JonesDirectorSell6,100$165.39$1,008,879.00View SEC Filing  
2/24/2015Heidi S MargulisVPSell3,665$164.44$602,672.60View SEC Filing  
8/22/2014Brian P LeclaireSVPSell3,250$123.04$399,880.00View SEC Filing  
5/15/2014Heidi MargulisVPSell3,345$119.56$399,928.20View SEC Filing  
5/12/2014Marissa PetersonDirectorSell2,026$123.30$249,805.80View SEC Filing  
3/19/2014James MurrayCOOSell36,833$116.59$4,294,359.47View SEC Filing  
3/18/2014M Todoroff ChristopherVPSell8,000$113.20$905,600.00View SEC Filing  
3/13/2014Bruce BroussardCEOSell109,000$109.84$11,972,560.00View SEC Filing  
3/10/2014Webster Roy DunbarDirectorSell9,587$110.30$1,057,446.10View SEC Filing  
12/4/2013Marissa PetersonDirectorSell1,147$103.54$118,760.38View SEC Filing  
12/2/2013M Todoroff ChristopherVPSell6,000$105.50$633,000.00View SEC Filing  
11/26/2013Heidi MargulisVPSell5,500$104.42$574,310.00View SEC Filing  
11/8/2013David Jr/Ky JonesDirectorSell11,000$95.00$1,045,000.00View SEC Filing  
9/5/2013Elizabeth D BierbowerInsiderSell17,673$96.01$1,696,784.73View SEC Filing  
8/30/2013Heidi MargulisVPSell3,319$93.35$309,828.65View SEC Filing  
8/29/2013David Jr/Ky JonesDirectorSell2,500$93.01$232,525.00View SEC Filing  
8/23/2013Elizabeth BierbowerInsiderSell6,063$94.00$569,922.00View SEC Filing  
8/15/2013Michael MccallisterDirectorSell138,817$91.49$12,700,367.33View SEC Filing  
8/13/2013Bruce PerkinsInsiderSell9,000$93.47$841,230.00View SEC Filing  
8/8/2013Steven McculleyVPSell10,000$92.54$925,400.00View SEC Filing  
8/7/2013James BloemCFOSell33,000$91.79$3,029,070.00View SEC Filing  
8/1/2013M Todoroff ChristopherVPSell39,596$90.30$3,575,518.80View SEC Filing  
6/24/2013Paul B K KusserowSVPSell34,219$84.60$2,894,927.40View SEC Filing  
6/18/2013Elizabeth D BierbowerInsiderSell8,033$83.29$669,068.57View SEC Filing  
5/30/2013James E MurrayCOOSell11,000$81.96$901,560.00View SEC Filing  
5/9/2013Michael B MccallisterDirectorSell281,312$77.72$21,863,568.64View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Humana (NYSE:HUM)
Latest Headlines for Humana (NYSE:HUM)
DateHeadline logoHumana hiring hundreds in Louisville for Medicare Advantage enrollments - July 20 at 11:13 PM logoGOP Obamacare retreat will hit insurers on the tax front - July 18 at 9:57 PM logoHumana Inc. (NYSE:HUM) Price Target Increased to $275.00 by Analysts at Bank of America Corporation - July 15 at 7:52 PM logoHumana Inc. (HUM) Receives "Buy" Rating from Piper Jaffray Companies - July 15 at 10:16 AM logoHumana's (HUM) Buy Rating Reiterated at Cowen and Company - July 15 at 8:14 AM logoHumana Inc. (HUM) Given Consensus Rating of "Buy" by Brokerages - July 14 at 11:32 AM logoHumana Inc. (NYSE:HUM) Stock Rating Reaffirmed by Credit Suisse Group - July 13 at 8:13 AM logoHumana and Oscar Health Enter Strategic Partnership to Offer ... - Business Wire (press release) - July 13 at 2:53 AM logoHumana and Oscar Health Enter Strategic Partnership to Offer Consumer-Focused, Technology-Driven Commercial Small Business Health Insurance, Beginning in Nashville Area - July 13 at 2:52 AM logoHumana And Oscar Partner To Sell Health Plans To Small Businesses - July 13 at 2:52 AM logo$13.64 Billion in Sales Expected for Humana Inc. (NYSE:HUM) This Quarter - July 12 at 9:14 AM logoOscar Health to join Humana in a small business venture - July 12 at 7:53 AM logoHumana and Oscar Health inks deal to offer commercial small business health insurance, beginning in Nashville area - July 12 at 7:34 AM logoHumana Inc. to Release Second Quarter 2017 Results on August 2, 2017 - Business Wire (press release) - July 11 at 5:40 AM logo$3.05 Earnings Per Share Expected for Humana Inc. (HUM) This Quarter - July 11 at 12:20 AM logoHumana Inc. to Release Second Quarter 2017 Results on August 2, 2017 - July 10 at 7:36 PM logoHumana hikes pay for board of directors - July 7 at 6:16 AM logoStudy of Managed Care Population Suggests Inferior Vena Cava Filters May Be Overused - July 7 at 6:16 AM logoHumana exec sells $4 million in company stock - July 5 at 8:17 PM logoHumana Inc. (HUM) Earns Buy Rating from Analysts at Citigroup Inc. - July 2 at 8:08 PM logoHumana subsidiary will expand into KC with 4 primary-care clinics - June 30 at 7:44 PM logoUPDATE 2-Aetna settles on New York for new headquarters in 2018 - June 30 at 7:44 PM logo[$$] Insurers’ Policy Warnings Raise Stakes in Health Fight - June 30 at 7:44 PM logoAetna settles on New York for new headquarters in 2018 - Reuters - June 30 at 4:58 AM logoTechnical Reports on Healthcare Equities -- UnitedHealth, Humana, Molina Healthcare, and Quorum Health - June 29 at 11:58 PM logoAnalyzing WellCare Health Plans (WCG) and Humana (HUM) - June 29 at 8:34 PM logoHumana Inc. (HUM) SVP Sells $1,193,040.00 in Stock - June 29 at 4:28 PM logoAnthem's Exit Creates Obamacare `Crisis' for Rural Nevadans - Bloomberg - June 29 at 5:15 AM logoHumana Foundation Awards $640000 to Knoxville Nonprofits to Improve Health of Community - Business Wire (press release) - June 29 at 12:14 AM logoHumana Foundation Awards $640,000 to Knoxville Nonprofits to Improve Health of Community - June 28 at 7:12 PM logoDon't Expect Failed Humana Deal To Quash Aetna's Desire For M&A - June 28 at 7:12 PM logoHumana Inc. (HUM) Forecasted to Earn FY2018 Earnings of $11.50 Per Share - June 26 at 9:18 AM logoHumana out of individual market, with or without Obamacare repeal - Reuters - June 24 at 6:08 PM logoHumana has a new position — and a new person — in its C-suite - June 23 at 11:05 PM logoCEO Broussard says Humana is out of the individual market, no matter what happens with Obamacare - June 23 at 6:03 PM logoHumana Names Sam Deshpande Chief Risk Officer - June 23 at 6:03 PM logoHere's What to Watch as the Senate Fights Over Healthcare Reform - June 23 at 6:03 PM logoFederal Trade Commission files petition to get court to enforce ... - Memphis Business Journal - June 22 at 6:25 PM logoHumana out of individual market, with or without Obamacare repeal - June 22 at 1:23 PM logoLegal update: FTC, Humana file motion re: Walgreens/Rite Aid investigation - June 22 at 1:23 PM logoHumana Inc. (HUM) Upgraded at BidaskClub - June 21 at 6:20 PM logoAnthem Blue Cross Blue Shield exits health care exchange - June 21 at 5:35 PM logoRecipe for Success: Humana Healthier Choices Program Celebrates 10 Years of Improving Health at Taste of Chicago - Business Wire (press release) - June 21 at 3:23 PM logoHumana Honored as Silver and Bronze Stevie® Award Winner in 2017 American Business Awards - Business Wire (press release) - June 21 at 3:23 PM logoHumana resists FTC subpoena, holding up Walgreens-Rite Aid merger - Louisville Business First - June 21 at 3:23 PM logoHumana resists FTC subpoena, holding up Walgreens-Rite Aid merger - June 21 at 3:23 PM logoAnthem Blue Cross Exits Obamacare In Two More Red States - June 21 at 3:23 PM logoHumana Honored as Silver and Bronze Stevie® Award Winner in 2017 American Business AwardsSM - June 21 at 3:23 PM logoCigna's 2017 growth may include Medicare Advantage acquisitions - June 21 at 3:23 PM logoHumana Inc. (HUM) Downgraded to "Hold" at Zacks Investment Research - June 21 at 9:36 AM



Humana (HUM) Chart for Saturday, July, 22, 2017

This page was last updated on 7/22/2017 by Staff